Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer

NCT00216125 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

243

Enrollment

OTHER

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Cisplatin
DRUG: Etoposide
RADIATION: Radiation
DRUG: Docetaxel

Sponsor

Nasser Hanna, M.D.

Collaborators

[object Object]
[object Object]